惰性淋巴瘤规范化治疗－08年NCCN治疗指南解读PPT.ppt

Actuarial survival curves for patients with indolent NHL treated at Stanford University from 1960 to 1976, 1976 to 1987, and 1987 to 1996 are essentially indistinguishable, which shows that the widespread use of single-agent or multiagent chemotherapy or combined modality therapy has not had a significant impact on the natural course of the disease.54 Slide 41: Rituximab + Fludarabine/Cyclophosphamide/Mitoxantrone in Relapsed or Primary Refractory Follicular Lymphoma The German Low-Grade Lymphoma Study Group (GLSG) recently published preliminary results of their randomized controlled pha